Loading
RELIEF THERAPEUTICS Holding AG：高管交易动态
RELIEF THERAPEUTICS Holding AG是一家医疗保健行业的上市公司。其高管通过SIX SER申报股份交易。自2025年10月18日以来，3位高管已提交13份申报。
期内所有公开市场交易均为卖出：3位高管共进行13笔卖出，金额€145万，没有一笔买入。期内单笔金额最大的是一笔卖出，金额€44.1万，于2025年12月15日公布。
大多数交易在发生当天即公开。在这段时间里，只有高管本人知道这笔交易。单笔卖出说明不了太多：高管卖出也可能是为了缴税、筹措资金或分散资产。
在其交易所跟踪的178家公司中，中位数为9份申报；本公司为13份申报，高于这一水平。我们关于RELIEF THERAPEUTICS Holding AG的记录可追溯至2024年，累计有0笔买入和51笔卖出。
如需在同一行业内比较，可查看Anixa Biosciences Inc和Vivos Inc的高管买入记录。数据来源：高管申报（SIX SER）。过往交易不代表未来收益。
高管申报
51
持股线
暂无
买入金额
暂无
暂无
卖出金额
€241万
51 笔 · 全部历史
谁在何时交易
买入卖出Anonymous (Executive member of the board of directors / member of senior management)35 笔卖出
Anonymous (Non-executive member of the board of directors)15 笔卖出
Anonymous (a non-executive member of the board of directors)1 笔卖出
分析师共识：看涨还是看跌？
分析师对 RELIEF THERAPEUTICS Holding AG 的评级为强烈买入（看涨），基于 1 位分析师。 平均目标价：CHF 2.60。
该评分只在所属市场内对买入进行排名。仅在经过回测的策略范围内的交易所提供建议仓位；其他市场的信号仍处于观察状态。并非投资建议。
基本面评分
在 24,166 家已排名公司中位列第 19,879
29.0
评分 / 100
价值7
质量51
FCF 收益率-28%
盈利收益率-38%
EV/EBITDA·
ROE-52%
毛利率92%
净利率·
负债/EBITDA·
支柱2/3
透明的价值 + 质量排名，独立于内部人交易信号。
财务数据
财年 2025财年截至 2025年12月 · cache
CHF 0.15
分析师一致预期
1 位分析师强烈买入
CHF 2.60目标价 CHF 2.60(+1613%)CHF 2.60
利润表
营业收入CHF 642k
毛利CHF 591k92% 利润率
EBITDA-CHF 8M-1246% 利润率
净利润-CHF 9.9M-1543.0% 利润率
估值
PER (forward)2.7x
P/Book0.7x
资产负债与现金
市值CHF 25.8M
总负债CHF 1.8M
自由现金流-CHF 7.2M
负债 / 股东权益0%
盈利能力与股权结构
ROE-51.6%
ROA-25.5%
内部人持股 %50.3%
机构持股 %18.6%
最新申报日期：2026年9月14日
申报51 总计
60,000 股@ CHF 0.170.042% 占市值100.0% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q9E00075
49,000 股@ CHF 1.25734.6% 占其流量ISIN CH1251125998SIX:T1Q1J00055
100,000 股@ CHF 1.584211.9% 占其流量ISIN CH1251125998SIX:T1Q1500032
65,000 股@ CHF 2.2511.0% 占其流量ISIN CH1251125998SIX:T1PCN00090
69,000 股@ CHF 2.210211.4% 占其流量ISIN CH1251125998SIX:T1PCM00092
37,000 股@ CHF 2.68487.5% 占其流量ISIN CH1251125998SIX:T1PCJ000A3
140,000 股@ CHF 1.650117.3% 占其流量ISIN CH1251125998SIX:T1PCG000A6
52,162 股@ CHF 1.054.1% 占其流量ISIN CH1251125998SIX:T1PCG00094
281,968 股@ CHF 1.461230.8% 占其流量ISIN CH1251125998SIX:T1PCF000B5
▼
Anonymous (Executive member of the board of directors / member of senior management)
600 股@ CHF 2.950.2% 占其流量ISIN CH1251125998SIX:T1PB600060
▼
Anonymous (Executive member of the board of directors / member of senior management)
5,000 股@ CHF 2.98431.7% 占其流量ISIN CH1251125998SIX:T1PB400065
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 3.0650.3% 占其流量ISIN CH1251125998SIX:T1PAV000D3
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,200 股@ CHF 3.11130.4% 占其流量ISIN CH1251125998SIX:T1PAU00099
▼
Anonymous (Executive member of the board of directors / member of senior management)
3,000 股@ CHF 2.74310.9% 占其流量ISIN CH1251125998SIX:T1PAE00085
▼
Anonymous (Executive member of the board of directors / member of senior management)
6,000 股@ CHF 2.79641.9% 占其流量ISIN CH1251125998SIX:T1PAD00053
▼
Anonymous (Executive member of the board of directors / member of senior management)
9,000 股@ CHF 2.97053.0% 占其流量ISIN CH1251125998SIX:T1PAA00067
7,500 股@ CHF 1.520.9% 占其流量ISIN CH1251125998SIX:T1PA900057
▼
Anonymous (Executive member of the board of directors / member of senior management)
6,000 股@ CHF 3.45172.3% 占其流量ISIN CH1251125998SIX:T1PA900065
5,000 股@ CHF 0.6650.2% 占其流量ISIN CH1251125998SIX:T1P8J00093
3,500 股@ CHF 0.6650.2% 占其流量ISIN CH1251125998SIX:T1P8I000B1
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,500 股@ CHF 2.17930.6% 占其流量ISIN CH1251125998SIX:T1P6600094
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,000 股@ CHF 2.25560.5% 占其流量ISIN CH1251125998SIX:T1P6500070
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,000 股@ CHF 2.27690.5% 占其流量ISIN CH1251125998SIX:T1P64000D5
▼
Anonymous (Executive member of the board of directors / member of senior management)
3,500 股@ CHF 2.3250.9% 占其流量ISIN CH1251125998SIX:T1P6300034
▼
Anonymous (Executive member of the board of directors / member of senior management)
8,000 股@ CHF 2.35782.1% 占其流量ISIN CH1251125998SIX:T1P5U000C6
51 条申报中的 25 条
关于 RELIEF THERAPEUTICS Holding AG
RELIEF THERAPEUTICS Holding AG 是一家瑞士公司，专注于开发罕见疾病和神经系统疾病的治疗方法。该公司在瑞士证券交易所 XSWX 上市。
同行业近期入选信号
我们的模型当前为推荐列表排序的买入。
全部推荐
